![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 18005 |
FusionGeneSummary for JAK1_ATF3 |
![]() |
Fusion gene information | Fusion gene name: JAK1_ATF3 | Fusion gene ID: 18005 | Hgene | Tgene | Gene symbol | JAK1 | ATF3 | Gene ID | 3716 | 467 |
Gene name | Janus kinase 1 | activating transcription factor 3 | |
Synonyms | JAK1A|JAK1B|JTK3 | - | |
Cytomap | 1p31.3 | 1q32.3 | |
Type of gene | protein-coding | protein-coding | |
Description | tyrosine-protein kinase JAK1 | cyclic AMP-dependent transcription factor ATF-3cAMP-dependent transcription factor ATF-3 | |
Modification date | 20180527 | 20180523 | |
UniProtAcc | P23458 | P18847 | |
Ensembl transtripts involved in fusion gene | ENST00000342505, ENST00000465376, | ENST00000366987, ENST00000341491, ENST00000366985, ENST00000492118, ENST00000336937, ENST00000366983, | |
Fusion gene scores | * DoF score | 6 X 4 X 5=120 | 4 X 4 X 2=32 |
# samples | 6 | 4 | |
** MAII score | log2(6/120*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/32*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: JAK1 [Title/Abstract] AND ATF3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | JAK1 | GO:0038110 | interleukin-2-mediated signaling pathway | 11909529 |
Hgene | JAK1 | GO:0046677 | response to antibiotic | 16280321 |
Tgene | ATF3 | GO:0000122 | negative regulation of transcription by RNA polymerase II | 8622660 |
Tgene | ATF3 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 16300731 |
Tgene | ATF3 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 24939851 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | BE719597 | JAK1 | chr1 | 65339137 | - | ATF3 | chr1 | 212791479 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-3CDS | ENST00000342505 | ENST00000366987 | JAK1 | chr1 | 65339137 | - | ATF3 | chr1 | 212791479 | + |
intron-3CDS | ENST00000342505 | ENST00000341491 | JAK1 | chr1 | 65339137 | - | ATF3 | chr1 | 212791479 | + |
intron-3CDS | ENST00000342505 | ENST00000366985 | JAK1 | chr1 | 65339137 | - | ATF3 | chr1 | 212791479 | + |
intron-intron | ENST00000342505 | ENST00000492118 | JAK1 | chr1 | 65339137 | - | ATF3 | chr1 | 212791479 | + |
intron-intron | ENST00000342505 | ENST00000336937 | JAK1 | chr1 | 65339137 | - | ATF3 | chr1 | 212791479 | + |
intron-intron | ENST00000342505 | ENST00000366983 | JAK1 | chr1 | 65339137 | - | ATF3 | chr1 | 212791479 | + |
intron-3CDS | ENST00000465376 | ENST00000366987 | JAK1 | chr1 | 65339137 | - | ATF3 | chr1 | 212791479 | + |
intron-3CDS | ENST00000465376 | ENST00000341491 | JAK1 | chr1 | 65339137 | - | ATF3 | chr1 | 212791479 | + |
intron-3CDS | ENST00000465376 | ENST00000366985 | JAK1 | chr1 | 65339137 | - | ATF3 | chr1 | 212791479 | + |
intron-intron | ENST00000465376 | ENST00000492118 | JAK1 | chr1 | 65339137 | - | ATF3 | chr1 | 212791479 | + |
intron-intron | ENST00000465376 | ENST00000336937 | JAK1 | chr1 | 65339137 | - | ATF3 | chr1 | 212791479 | + |
intron-intron | ENST00000465376 | ENST00000366983 | JAK1 | chr1 | 65339137 | - | ATF3 | chr1 | 212791479 | + |
Top |
FusionProtFeatures for JAK1_ATF3 |
![]() |
Hgene | Tgene |
JAK1 | ATF3 |
Tyrosine kinase of the non-receptor type, involved inthe IFN-alpha/beta/gamma signal pathway (PubMed:7615558). Kinasepartner for the interleukin (IL)-2 receptor (PubMed:11909529).{ECO:0000269|PubMed:11909529, ECO:0000269|PubMed:7615558}. | This protein binds the cAMP response element (CRE)(consensus: 5'-GTGACGT[AC][AG]-3'), a sequence present in manyviral and cellular promoters. Represses transcription frompromoters with ATF sites. It may repress transcription bystabilizing the binding of inhibitory cofactors at the promoter.Isoform 2 activates transcription presumably by sequesteringinhibitory cofactors away from the promoters. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for JAK1_ATF3 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for JAK1_ATF3 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for JAK1_ATF3 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | JAK1 | P23458 | DB08877 | Ruxolitinib | Tyrosine-protein kinase JAK1 | small molecule | approved |
Hgene | JAK1 | P23458 | DB08895 | Tofacitinib | Tyrosine-protein kinase JAK1 | small molecule | approved|investigational |
Top |
RelatedDiseases for JAK1_ATF3 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | ATF3 | C0027765 | nervous system disorder | 2 | CTD_human |
Tgene | ATF3 | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human |
Tgene | ATF3 | C0011570 | Mental Depression | 1 | PSYGENET |
Tgene | ATF3 | C0011581 | Depressive disorder | 1 | PSYGENET |
Tgene | ATF3 | C0011853 | Diabetes Mellitus, Experimental | 1 | CTD_human |
Tgene | ATF3 | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | CTD_human |
Tgene | ATF3 | C0021400 | Influenza | 1 | CTD_human |
Tgene | ATF3 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Tgene | ATF3 | C0023903 | Liver neoplasms | 1 | CTD_human |
Tgene | ATF3 | C0031117 | Peripheral Neuropathy | 1 | CTD_human |
Tgene | ATF3 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Tgene | ATF3 | C0740392 | Infarction, Middle Cerebral Artery | 1 | CTD_human |
Tgene | ATF3 | C0848558 | Hypospadias | 1 | CTD_human |
Tgene | ATF3 | C0878544 | Cardiomyopathies | 1 | CTD_human |
Tgene | ATF3 | C0919267 | ovarian neoplasm | 1 | CTD_human |